BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X952. A total of 6 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,119,571 | -64.3% | 118,300 | -76.7% | 0.00% | -66.7% |
| Q2 2023 | $8,742,760 | +91.4% | 508,300 | +84.5% | 0.00% | +50.0% |
| Q1 2023 | $4,567,790 | +2025.7% | 275,500 | +877.0% | 0.00% | – |
| Q4 2022 | $214,884 | -61.4% | 28,200 | -49.6% | 0.00% | – |
| Q3 2022 | $557,000 | +24.9% | 56,000 | +14.1% | 0.00% | – |
| Q2 2022 | $446,000 | – | 49,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 200,000 | $3,316 | 0.12% |
| GROUP ONE TRADING, L.P. | 324,000 | $5,371,920 | 0.02% |
| SIMPLEX TRADING, LLC | 648,600 | $10,753 | 0.01% |
| JANE STREET GROUP, LLC | 275,500 | $4,567,790 | 0.00% |
| JPMORGAN CHASE & CO | 8,000 | $133,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |